Musings from The Power List: Gerrit Renner

Gerrit Renner explains why an analytical measurement does not end at the detector – and why trustworthy AI will depend on transparent, traceable data

October 27, 2026
5 min

The Analytical Scientist

Overview

Gerrit Renner describes research aimed at preserving uncertainty, quality, and provenance throughout analytical data processing, from signal acquisition to scientific interpretation. He argues that machine-actionable data and transparent processing are important as analytical workflows become more automated and incorporate AI.

Background

Analytical workflows can involve many transformations between a detector signal and a reported result, including preprocessing, feature detection, integration, and modeling. Renner notes that these steps introduce assumptions and uncertainty that may be difficult to reconstruct if processing decisions and context are not retained. He frames data structures, algorithms, statistics, and interpretation as parts of the same measurement chain. His perspective emphasizes FAIR data as a property of the workflow from acquisition onward, rather than a final-stage activity.

Data Highlights

The article is an interview and reports no numerical study or trial data.

Key Findings

Renner’s research develops data-processing and chemometric approaches intended to retain uncertainty, quality, and provenance across analytical workflows.
He identifies centroiding, feature detection, integration, and modeling as processing steps that add assumptions and uncertainty.
He advocates transparent, quantitative processing, including uncertainty estimates and quality measures that can be propagated through workflows.
He describes machine-actionable analytical data as results accompanied by metadata, provenance, uncertainty, and semantic meaning.
Renner argues that FAIR data should be maintained throughout acquisition and processing, because context and provenance may be lost if FAIR practices are postponed until project completion.
He describes his career direction as arising from work at the interface of analytical chemistry and data science, particularly with complex mass-spectrometric data.

Clinical Implications

The interview does not report clinical validation data or provide recommendations for clinical laboratories. Renner discusses analytical data processing, provenance, uncertainty, and machine-actionable data in the context of analytical science.

Conclusion

Renner argues that analytical data should retain metadata, provenance, uncertainty, and semantic meaning throughout acquisition and processing. He says that structured, traceable data will be important for machine-actionable analytical workflows and trustworthy AI-assisted interpretation.